Literature DB >> 24078663

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

T Waddell1, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24078663     DOI： 10.1093/annonc/mdt344

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  121 in total

1.  Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy.

Authors:  Kenji Ishido; Katsuhiko Higuchi; Satoshi Tanabe; Mizutomo Azuma; Tohru Sasaki; Chikatoshi Katada; Shouko Komori; Kazushige Hayakawa; Kei Hosoda; Keishi Yamashita; Natsuya Katada; Wasaburo Koizumi
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

Review 2.  Surgical management of gastric cancer: the East vs. West perspective.

Authors:  Maki Yamamoto; Omar M Rashid; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2015-02

3.  Application of laparoscopy in the diagnosis and treatment of gastric cancer.

Authors:  Ziyu Li; Jiafu Ji
Journal:  Ann Transl Med       Date:  2015-06

Review 4.  Redefining early gastric cancer.

Authors:  Savio G Barreto; John A Windsor
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

5.  Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.

Authors:  Y Wang; J Zhang; S Guo; Z Dong; X Meng; G Zheng; D Yang; Z Zheng; Y Zhao
Journal:  Clin Transl Oncol       Date:  2019-03-22       Impact factor: 3.405

6.  Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Authors:  Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt
Journal:  Gastric Cancer       Date:  2017-07-24       Impact factor: 7.370

Review 7.  Technical pro & cons of the laparoscopic lymphadenectomy.

Authors:  Riccardo Rosati; Paolo Parise; Fabio Giannone Codiglione
Journal:  Transl Gastroenterol Hepatol       Date:  2016-12-27

8.  Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.

Authors:  Mehmet Ali Nahit Sendur; Nuriye Ozdemir; Tahsin Özatlı; Ozan Yazıcı; Sercan Aksoy; Ahmet Siyar Ekinci; Doğan Yazılıtaş; Yusuf Günaydın; Berna Oksuzoglu; Mustafa Benekli; Nurullah Zengin
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

9.  Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study.

Authors:  Yongjia Yan; Annie Yang; Li Lu; Zhicheng Zhao; Chuan Li; Weidong Li; Joseph Chao; Tong Liu; Yuman Fong; Weihua Fu; Yanghee Woo
Journal:  Ann Surg Oncol       Date:  2020-08-29       Impact factor: 5.344

10.  Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.

Authors:  Manish A Shah; Yoon-Koo Kang; Peter C Thuss-Patience; Atsushi Ohtsu; Jaffer A Ajani; Eric Van Cutsem; Silke Hoersch; Marie-Laurence Harle-Yge; Sanne Lysbet de Haas
Journal:  Gastric Cancer       Date:  2019-01-31       Impact factor: 7.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.